Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.25
Bid: 24.00
Ask: 24.50
Change: -1.00 (-3.96%)
Spread: 0.50 (2.083%)
Open: 25.25
High: 25.25
Low: 24.25
Prev. Close: 25.25
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: ING Real, Intellego, Oxford Intruments...

Wed, 20th Jan 2010 13:10

ING UK Real Estate Income Trust will repay £15m of debt through the purchase and cancellation of loan notes at a discount to nominal value in two separate transactions.The transaction will result in a one off gain to NAV expected to be in the order of £680,000, and will also save over £719,000 per annum in interest charges."This is an opportunistic purchase, enabling us to enhance both the underlying NAV and income account, whilst de-risking the overall portfolio by maintaining the current LTV ratio and improving the interest cover position, fund manager Michael Morris said.Angus Forrest, training and e-learning group Intellego's chairman, says the firm has won a material order with a leading retail specialist to provide productivity improvement services for the next 12 months. Order intake in the third quarter of the year ending 31 March 2010 was £898,000.Oxford Instruments performance from October to January was in line with the board's expectations and above the same period in the prior year, aided by the effects of the restructuring programme implemented last year and favourable currency movements. Research markets remain robust. The tentative signs of improvement in Industrial markets continue, albeit from a low level and visibility remains limited, it added.Lower than expected endoscopy sales and higher field costs will mean Puricore's earnings this year missing targets, though it says the miss will not be significant. Fourth quarter sales in 2009 were $10.4m, up 75%, while revenue for the year was about $40m, up 19%. "In 2010, the company anticipates cash flow profitability in PuriCore's Endoscopy business in the UK and continued significant progress in the Food Safety business in both the US and Canada," it said. Cake and bread maker Finsbury Food Group has appointed Stephen Boyd as its new finance boss and confirmed it continues to trade in line with market expectations.The 47-year-old, who has experience at WT Foods, Noon Products and Golden Wonder, replaces Lisa Morgan who'll leave the company by the end of March 2010.Renewable fuels company GTL Resources had a record December, with subsidiary Illinois River Energy selling 9.8 million gallons of ethanol and 24.2 thousand tons of dried distillers grains with solubles.'With the recent commodity margin rally in the ethanol industry coupled with GTL's strong operational performance since September 2009, the group expects to report improved results in the second half,' said the firm.Asset finance company 1pm said trading has been in line with management expectations since its last trading update in October. Revenue in the 6 months to 30 November 2009 edged higher to £0.68m from £0.66m the year before, but the loss before tax widened to £0.23m from £0.01m.Bad debt write-offs in the period were £95,000, while general bad debt provisions of £120,000 were accrued as a result of a number of customers going bankrupt during the reporting period.Brulines, which provides monitoring systems and data management services for the UK leisure sector, has won a contract to supply vending telemetry hardware over a period of three years to an unnamed international consumer goods company.Chinese specialist engineering company China Wonder has taken a £0.2m loan from Wonder Employees Capital Limited (WECL), a company wholly owned by Qingjie Zhao, a substantial shareholder.The loan accrues interest at a rate of 5% per annum. The loan agreement gives WECL the right to convert the loan into ordinary shares in the capital of China Wonder at a price of 10p per share. Scientists at the Institute of Cancer Research and Sareum have developed a chemical compounds that increase the effectiveness of current cancer therapeutics.Media services business Dawson Holdings is on the look-out for a new finance director after the current position holder, Adrian Wood, announced his intention to retire from the role on 31 March. Wood will stay on as company secretary until the end of June.
More News
11 Aug 2020 12:36

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

Read more
24 Jul 2020 13:56

UK TRADING UPDATE SUMMARY: Naked Wines Chair Leaves, Online Sales Grow

UK TRADING UPDATE SUMMARY: Naked Wines Chair Leaves, Online Sales Grow

Read more
3 Jun 2020 18:09

Sareum Raises GBP1 Million For TYK2/JAK1 Research Programmes

Sareum Raises GBP1 Million For TYK2/JAK1 Research Programmes

Read more
3 Jun 2020 10:56

UK WINNERS & LOSERS SUMMARY: M&S Gains, B&M Loses On Jefferies Ratings

UK WINNERS & LOSERS SUMMARY: M&S Gains, B&M Loses On Jefferies Ratings

Read more
2 Jun 2020 17:46

Sareum Looks To Raise Cash For TYK2/JAK1 Research Programmes

Sareum Looks To Raise Cash For TYK2/JAK1 Research Programmes

Read more
26 Mar 2020 11:46

Sareum Loss Narrows; Could Secure GBP900,000 From China License Deal

Sareum Loss Narrows; Could Secure GBP900,000 From China License Deal

Read more
17 Dec 2019 13:20

Sareum Holdings Happy With Progress Despite Mixed Year

Sareum Holdings Happy With Progress Despite Mixed Year

Read more
17 Dec 2019 11:55

Sareum Expects Possible Significant Delay To Sierra Milestone Payments

Sareum Expects Possible Significant Delay To Sierra Milestone Payments

Read more
10 Dec 2019 15:57

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
15 Oct 2019 11:43

Sareum Narrows Annual Loss As Immunotherapy Programmes Progress

Sareum Narrows Annual Loss As Immunotherapy Programmes Progress

Read more
27 Sep 2019 09:20

Sareum's SAR-20351 Inhibitor Reduces Tumour Growth In Various Cancers

Sareum's SAR-20351 Inhibitor Reduces Tumour Growth In Various Cancers

Read more
27 Sep 2019 09:10

Sareum Holdings upbeat ahead of cancer research presentation

(Sharecast News) - Specialist small molecule drug development company Sareum Holdings announced on Friday that it will present new preclinical data from its 'SDC-1802 TYK2/JAK1' inhibitor cancer research programme at the American Association for Cancer Research (AACR) National Cancer Institute (NCI) European Organisation for Research and Treatment of Cancer (EORTC) international conference, in late October in Boston, Massachusetts.

Read more
27 Aug 2019 13:24

Sareum Optimistic On Cancer Treatment As Partner Changes Focus

(Alliance News) - Small molecule drug developer Sareum Holdings PLC on Tuesday said investee Sierra Oncology will need to look at new options to progress development of a key drug.Sierra to

Read more
27 Aug 2019 08:35

Sareum Holdings expects broadly flat interim losses

(Sharecast News) - Drug developer Sareum expects interim losses to be broadly flat year-on-year as it continues to focus on the development of multiple treatments for cancer and autoimmune diseases.

Read more
25 Jun 2019 18:33

Sareum Raises GBP513,000 Through Discounted Placing For Pipeline Push

(Alliance News) - Sareum Holdings PLC said Tuesday it raised GBP513,000 through a discounted share placing by Hybridan LLP, whilst also opening the offer to retail investors through drug firm at ,

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.